Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
AssigneeThe Scripps Research Institute
InventorsPaul Schimmel, Keisuke Wakasugi, Martin Friedlander
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Scripps Research Institute
InventorsPaul Schimmel, Keisuke Wakasugi, Martin Friedlander
Estimating the term…
The invention provides a method for inhibiting ocular neovascularization in a patient. The method comprises administering to a patient an ocular neovascularization inhibiting amount of a water-soluble polypeptide selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 7, and an ocular neovascularization inhibiting fragment thereof, which includes at least one of amino acid residue signature sequences HVGH (SEQ ID NO:10) and KMSAS (SEQ ID NO:11). A method for assaying the angiogenesis inhibiting activity of a composition is also provided
A method of assaying the angiogenesis inhibiting activity of a composition, the method comprising:
A pharmaceutical composition comprising an isolated nucleic acid encoding a tryptophanyl-t tRNA synthetase consisting of a nucleotide sequence encoding a water-soluble polypeptide fragment of human tryptophanyl-tRNA synthetase, the region of the nucleotide sequence encoding said fragment consisting of a nucleotide sequence that is at least 95 percent identical to the sequence of a polynucleotide selected from the group consisting of a polynucleotide of SEQ ID NO:
Dependencies are inferred from the claim text.